2025. Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program. SKIN The Journal of Cutaneous Medicine. 9, 4 (Jul. 2025), s583. DOI:https://doi.org/10.25251/ed52rz19.